Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA.
Novartis Institutes for BioMedical Research, Basel, Switzerland.
Clin Pharmacol Ther. 2019 Jan;105(1):53-60. doi: 10.1002/cpt.1272. Epub 2018 Dec 5.
The impressive increase in lifespan that occurred in the 20th century has driven a boom in age-associated degeneration resulting from senescence. Geriatric syndromes, such as sarcopenia and frailty, do not fall neatly into classical medical definitions of disease because they result from subtle declines in physiological function that occur over many years instead of specific organ-related pathology. These conditions have become more clinically prominent with the aging population and are the focus of research in regenerative medicine. Two major approaches are being pursued: the first targets specific organs that are adversely affected by senescence, and the second targets senescence pathways themselves, with the goal of favorably altering the affected physiology. This review will highlight a few examples of recent applications of both of these approaches to illustrate the potential of the application of a regenerative medicine approach to improve the quality of life and independence in older adults.
20 世纪寿命的显著延长导致了与衰老相关的退行性病变的爆发。老年综合征,如肌肉减少症和虚弱,并不符合经典的医学疾病定义,因为它们是由于生理功能多年来逐渐下降而导致的,而不是特定器官相关的病理学。随着人口老龄化,这些情况在临床上更加突出,是再生医学研究的重点。目前主要有两种方法:第一种针对受衰老影响的特定器官,第二种针对衰老途径本身,目的是改善受影响的生理机能。这篇综述将重点介绍这两种方法的一些最新应用,说明应用再生医学方法改善老年人生活质量和独立性的潜力。